Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Osteopontin is a prognostic biomarker in non-small cell lung cancer.

BMC cancer - 11 Nov 2013

Kongsgaard Ane, Boye Kjetil, Oijordsbakken Miriam, Lund-Iversen Marius, Halvorsen Ann Rita, Solberg Steinar K, Berge Gisle, Helland Aslaug, Brustugun Odd Terje, Mælandsmo Gunhild M

Abstract excerpt

BACKGROUND: In a previously published report we characterized the expression of the metastasis-associated proteins S100A4, osteopontin (OPN) and ephrin-A1 in a prospectively collected panel of non-small cell lung cancer (NSCLC) tumors. The aim of the present follow-up study was to investigate the prognostic impact of these potential biomarkers in the same patient cohort. In addition, circulating serum levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasm Grading
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Osteopontin

Share to Patient Outcome Assessment

Share to S100 Proteins

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 24215488
DOI: 10.1186/1471-2407-13-540
PMCID: PMC3830440

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Osteopontin is a prognostic biomarker in non-small cell lung cancer.PMID 24215488Read ↗

Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis.Semantic proximity Read ↗

Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer.Semantic proximity Read ↗

Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung CancerSemantic proximity Read ↗

Human osteopontin: Potential clinical applications in cancer (Review)Semantic proximity Read ↗

Role of osteopontin in the pathophysiology of cancerSemantic proximity Read ↗

Associations Between OPN-CD44 Axis Genetic Variability, Plasma Osteopontin, and Treatment Outcomes in Head and Neck Squamous Cell Carcinoma.Semantic proximity Read ↗

Role of osteopontin in tumour progressionSemantic proximity Read ↗

Identification and quantification of osteopontin splice variants in the plasma of lung cancer patients using immunoaffinity capture and targeted mass spectrometrySemantic proximity Read ↗

Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.Semantic proximity Read ↗

The role of Osteopontin in tumor metastasis.Semantic proximity Read ↗

Role of osteopontin in cellular signaling and metastatic phenotype.Semantic proximity Read ↗

Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.